NCT06739031View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors

NANot yet recruitingINTERVENTIONAL

Enrollment

126

Participants

Timeline

Start Date

December 25, 2024

Primary Completion Date

December 25, 2026

Study Completion Date

August 25, 2027

Conditions

NSCLC

Interventions

DEVICE

PEF Treatment

PEF Energy ablation of lung tumors

Trial Locations (1)

Unknown

Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine,, Shanghai

All Listed Sponsors

lead

Energenx Medical LTD.

INDUSTRY

NCT06739031 - Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors | Biotech Hunter | Biotech Hunter